Anti-aging compounds targeting Alzheimer’s move closer to human trials

Exciting research from a team at the Salk Institute is developing a new subclass of anti-aging compounds that are hoped to extend lifespan, reduce the molecular markers of aging, and slow the onset of neurodegenerative diseases such as Alzheimer’s. The work is on the cusp of commencing two human clinical trials investigating the efficacy of two compounds derived from natural sources.

Rich Haridy

https://newatlas.com/alzheimers-anti-aging-compound-salk/57215/?utm_medium=email&utm_campaign=2018-11-14%20153149%20USA%20Daily%20Basic%202018-11-14%20154452%20Official%20definition%20of%20a%20kilogram%20set%20to%20change%20this%20week&utm_content=2018-11-14%20153149%20USA%20Daily%20Basic%202018-11-14%20154452%20Official%20definition%20of%20a%20kilogram%20set%20to%20change%20this%20week+CID_be2c7d143531833da0c52d05c3f9b2c6&utm_source=Campaign%20Monitor&utm_term=Read%20more